AbbVie Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by AbbVie Inc. on March 4, 2022, covering the event date of February 28, 2022. The filing pertains to corporate governance changes regarding the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific corporate event and does not contain financial performance data.
Material Changes
The material change reported is the departure of a director. Edward M. Liddy informed the company of his decision to retire as a director, effective as of the 2022 annual shareholders meeting scheduled for May 2022.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, risks, contingencies, or unusual items. The document strictly addresses the director's retirement.
Key Facts for Investor Verification
- Edward M. Liddy is retiring from the Board of Directors.
- The retirement is effective at the 2022 annual shareholders meeting in May.
- The filing was signed by Timothy J. Richmond, Executive Vice President and Chief Human Resources Officer.
- No financial data or strategic updates are included in this specific report.